Free Trial
NASDAQ:ATOS

Atossa Genetics (ATOS) Stock Price, News & Analysis

Atossa Genetics logo
$0.94 +0.05 (+5.70%)
Closing price 07/11/2025 04:00 PM Eastern
Extended Trading
$0.93 0.00 (-0.48%)
As of 07/11/2025 07:53 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About Atossa Genetics Stock (NASDAQ:ATOS)

Key Stats

Today's Range
$0.88
$0.96
50-Day Range
$0.76
$1.03
52-Week Range
$0.55
$1.66
Volume
969,883 shs
Average Volume
760,282 shs
Market Capitalization
$121.23 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$6.17
Consensus Rating
Buy

Company Overview

Atossa Genetics Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
58th Percentile Overall Score

ATOS MarketRank™: 

Atossa Genetics scored higher than 58% of companies evaluated by MarketBeat, and ranked 446th out of 944 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Atossa Genetics has received a consensus rating of Buy. The company's average rating score is 3.33, and is based on 2 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Atossa Genetics has only been the subject of 2 research reports in the past 90 days.

  • Read more about Atossa Genetics' stock forecast and price target.
  • Earnings Growth

    Earnings for Atossa Genetics are expected to decrease in the coming year, from ($0.22) to ($0.28) per share.

  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Atossa Genetics is -4.47, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Atossa Genetics is -4.47, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

  • Price to Book Value per Share Ratio

    Atossa Genetics has a P/B Ratio of 1.65. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Atossa Genetics' valuation and earnings.
  • Percentage of Shares Shorted

    3.91% of the float of Atossa Genetics has been sold short.
  • Short Interest Ratio / Days to Cover

    Atossa Genetics has a short interest ratio ("days to cover") of 4.9.
  • Change versus previous month

    Short interest in Atossa Genetics has recently decreased by 37.06%, indicating that investor sentiment is improving significantly.
  • Dividend Yield

    Atossa Genetics does not currently pay a dividend.

  • Dividend Growth

    Atossa Genetics does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    3.91% of the float of Atossa Genetics has been sold short.
  • Short Interest Ratio / Days to Cover

    Atossa Genetics has a short interest ratio ("days to cover") of 4.9.
  • Change versus previous month

    Short interest in Atossa Genetics has recently decreased by 37.06%, indicating that investor sentiment is improving significantly.
  • News Sentiment

    Atossa Genetics has a news sentiment score of 0.94. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This news sentiment score is similar to the average news sentiment of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for Atossa Genetics this week, compared to 2 articles on an average week.
  • Search Interest

    22 people have searched for ATOS on MarketBeat in the last 30 days. This is an increase of 175% compared to the previous 30 days.
  • MarketBeat Follows

    5 people have added Atossa Genetics to their MarketBeat watchlist in the last 30 days.
  • Insider Buying vs. Insider Selling

    In the past three months, Atossa Genetics insiders have bought more of their company's stock than they have sold. Specifically, they have bought $9,890.00 in company stock and sold $0.00 in company stock.

  • Percentage Held by Insiders

    Only 7.60% of the stock of Atossa Genetics is held by insiders.

  • Percentage Held by Institutions

    Only 12.74% of the stock of Atossa Genetics is held by institutions.

  • Read more about Atossa Genetics' insider trading history.
Receive ATOS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Atossa Genetics and its competitors with MarketBeat's FREE daily newsletter.

ATOS Stock News Headlines

Trump wipes out trillions overnight…
Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out nearly $5 trillion in wealth from the S&P 500 and $6.4 trillion from the Dow Jones… Not to mention the countless trillions of dollars lost in every market around the world… leaving the major political powers scrambling in fear of Trump’s next move.
See More Headlines

ATOS Stock Analysis - Frequently Asked Questions

Atossa Genetics' stock was trading at $0.9441 at the start of the year. Since then, ATOS shares have decreased by 0.6% and is now trading at $0.9385.

Atossa Genetics Inc. (NASDAQ:ATOS) released its quarterly earnings data on Tuesday, May, 13th. The company reported ($0.05) EPS for the quarter, topping the consensus estimate of ($0.06) by $0.01.

Shares of Atossa Genetics reverse split on Friday, April 20th 2018.The 1-12 reverse split was announced on Friday, April 20th 2018. The number of shares owned by shareholders was adjusted after the closing bell on Thursday, April 19th 2018. An investor that had 100 shares of stock prior to the reverse split would have 8 shares after the split.

Shares of ATOS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Atossa Genetics investors own include Zomedica (ZOM), AU Optronics (AUOTY), Voyager Therapeutics (VYGR), DiamondRock Hospitality (DRH), Waste Connections (WCN), American Water Works (AWK) and The RMR Group (RMR).

Company Calendar

Last Earnings
5/13/2025
Today
7/11/2025
Next Earnings (Estimated)
8/11/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED INSTRUMENTS
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:ATOS
CIK
1488039
Employees
8
Year Founded
2009

Price Target and Rating

High Price Target
$7.50
Low Price Target
$4.00
Potential Upside/Downside
+557.1%
Consensus Rating
Buy
Rating Score (0-4)
3.33
Research Coverage
3 Analysts

Profitability

EPS (Trailing Twelve Months)
($0.21)
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$25.50 million
Net Margins
N/A
Pretax Margin
N/A
Return on Equity
-33.90%
Return on Assets
-31.53%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
12.67
Quick Ratio
12.67

Sales & Book Value

Annual Sales
N/A
Price / Sales
N/A
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
$0.57 per share
Price / Book
1.65

Miscellaneous

Outstanding Shares
129,170,000
Free Float
119,353,000
Market Cap
$121.23 million
Optionable
Optionable
Beta
0.90

Social Links

10 Stocks Set to Soar in Summer 2025 Cover

Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Summer 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.

Get This Free Report

This page (NASDAQ:ATOS) was last updated on 7/12/2025 by MarketBeat.com Staff
From Our Partners